Correvio Pharma (CORV) Misses Q1 EPS by 3c, Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. DPZ
2. NVDA
3. BAC
4. UNH
5. ORCL
6. GS
7. DVLT
8. AVAV
9. LQDA
10. ACI

Go back to Correvio Pharma (CORV) Misses Q1 EPS by 3c, Revenues Miss

Correvio Reports First Quarter 2019 Financial Results

May 8, 2019 8:00 AM EDT

Mark H.N. Corrigan, MD Commences Role as CEO, effective March 14, 2019

Company on Track to Resubmit Brinavess NDA in Q2 2019

Management to Host Conference Call and Webcast Today, May 8, 2019 at 8:30 a.m. Eastern (5:30 a.m. Pacific)

NASDAQ: CORV  TSX: CORV

VANCOUVER, May 8, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today reported financial results for its first quarter ended March 31, 2019 and commented on recent... More